» Articles » PMID: 30766602

Melittin Inhibition and Eradication Activity for Resistant Polymicrobial Biofilm Isolated from a Dairy Industry After Disinfection

Overview
Journal Int J Microbiol
Publisher Wiley
Specialty Microbiology
Date 2019 Feb 16
PMID 30766602
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The emerging concern about the increase of antibiotic resistance and associated biofilm has encouraged scientists to look for alternative antibiotics such as antimicrobial peptides (AMPs). This study evaluated the ability of melittin to act as an antibacterial biofilm inhibitor and biofilm remover considering isolates from dairy industry. Minimum inhibitory concentrations (MICs), minimum bactericidal concentrations (MBCs), minimum biofilm inhibitory concentrations (MBICs), and biofilm removal activities were studied in polymicrobial biofilms produced from isolates. MIC and MBC were set at 1-3 g/mL and 25-50 g/mL for Gram-positive and Gram-negative bacteria, respectively. Results demonstrated a good MBIC reaching 85% inhibition ability and a good activity and better penetration in deeper layers against the mixed preformed biofilm, thereby increasing its activity against all isolates also at the lowest tested concentrations. Melittin showed interesting characteristics suggesting its potential to act as an antimicrobial agent for polymicrobial biofilm from dairy industry even in environmental isolates.

Citing Articles

Antimicrobial proteins from oyster hemolymph improve the efficacy of conventional antibiotics.

Summer K, Guo Q, Liu L, Barkla B, Giles S, Benkendorff K PLoS One. 2025; 20(1):e0312305.

PMID: 39836702 PMC: 11750097. DOI: 10.1371/journal.pone.0312305.


Survey of probable synergism between melittin and ciprofloxacin, rifampicin, and chloramphenicol against multidrug-resistant .

Sedaghati M, Akbari R, Lotfollahi Hagghi L, Yousefi S, Mesbahi T, Delfi M Front Microbiol. 2024; 15:1480299.

PMID: 39640853 PMC: 11617520. DOI: 10.3389/fmicb.2024.1480299.


Cell-Free Systems: Ideal Platforms for Accelerating the Discovery and Production of Peptide-Based Antibiotics.

Park H, Jin H, Kim D, Lee J Int J Mol Sci. 2024; 25(16).

PMID: 39201795 PMC: 11354240. DOI: 10.3390/ijms25169109.


Hybrid bio-nanoporous peptide loaded-polymer platforms with anticancer and antibacterial activities.

Icriverzi M, Florian P, Bonciu A, Dumitrescu L, Moldovan A, Pelinescu D Nanoscale Adv. 2024; 6(8):2038-2058.

PMID: 38633049 PMC: 11019497. DOI: 10.1039/d3na00947e.


A comprehensive investigation of the medicinal efficacy of antimicrobial fusion peptides expressed in probiotic bacteria for the treatment of pan drug-resistant (PDR) infections.

Safarpour-Dehkordi M, Chabok O, Asgari M, Khademi R, Doosti A Arch Microbiol. 2024; 206(3):93.

PMID: 38329629 DOI: 10.1007/s00203-023-03823-2.


References
1.
Cuthbertson B, Shepard E, Chapman R, Gross P . Diversity of the penaeidin antimicrobial peptides in two shrimp species. Immunogenetics. 2002; 54(6):442-5. DOI: 10.1007/s00251-002-0487-z. View

2.
Galdiero S, Capasso D, Vitiello M, DIsanto M, Pedone C, Galdiero M . Role of surface-exposed loops of Haemophilus influenzae protein P2 in the mitogen-activated protein kinase cascade. Infect Immun. 2003; 71(5):2798-809. PMC: 153271. DOI: 10.1128/IAI.71.5.2798-2809.2003. View

3.
Koumanov K, Momchilova A, Wolf C . Bimodal regulatory effect of melittin and phospholipase A2-activating protein on human type II secretory phospholipase A2. Cell Biol Int. 2003; 27(10):871-7. DOI: 10.1016/s1065-6995(03)00176-8. View

4.
Raghuraman H, Chattopadhyay A . Melittin: a membrane-active peptide with diverse functions. Biosci Rep. 2006; 27(4-5):189-223. DOI: 10.1007/s10540-006-9030-z. View

5.
Stepanovic S, Vukovic D, Hola V, Di Bonaventura G, Djukic S, Cirkovic I . Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 2007; 115(8):891-9. DOI: 10.1111/j.1600-0463.2007.apm_630.x. View